Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07PAF
|
|||
| Former ID |
DNC010647
|
|||
| Drug Name |
PHENMEDIPHAM
|
|||
| Synonyms |
Phenmedipham; 13684-63-4; 3-((Methoxycarbonyl)amino)phenyl m-tolylcarbamate; Fenmedifam; BETANAL; Phenmediphame; Kemifam; Spin-aid; Synbetan P; Schering 4072; Schering-38584; Caswell No. 648B; Morton EP 452; UNII-UJE31KXP78; Phenmediphame [ISO-French]; EP-452; SN 4075; CCRIS 6091; Phenmedipham [ANSI:BSI:ISO]; SN-38584; HSDB 1402; Methyl 3-(3-methylcarbaniloyloxy)carbanilate; Methyl 3-(m-tolylcarbamoyloxy)phenylcarbamate; EINECS 237-199-0; [3-(methoxycarbonylamino)phenyl] N-(3-methylphenyl)carbamate; 3-(Carbomethoxyamino)phenyl 3-me
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H16N2O4
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)NC(=O)OC2=CC=CC(=C2)NC(=O)OC
|
|||
| InChI |
1S/C16H16N2O4/c1-11-5-3-6-12(9-11)18-16(20)22-14-8-4-7-13(10-14)17-15(19)21-2/h3-10H,1-2H3,(H,17,19)(H,18,20)
|
|||
| InChIKey |
IDOWTHOLJBTAFI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 13684-63-4
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:81734
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inh... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6793-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.